Literature DB >> 22310942

Interstitial cystitis: diagnosis and management.

Monika Vij1, Sushma Srikrishna, Linda Cardozo.   

Abstract

Interstitial cystitis/painful bladder syndrome is a chronic condition that causes debilitating bladder pain which can be associated with urgency, frequency and nocturia. Its cause is not clear and it is still a disease diagnosed by exclusion. Oral or intravesical therapies are the main stay of treatment whilst surgical procedures are reserved for refractory cases. This condition usually warrants a multidisciplinary approach for optimum outcome. This article gives an overview of the changes in definition, aetiopathogenesis and available treatments. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22310942     DOI： 10.1016/j.ejogrb.2011.12.014

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN： 0301-2115            Impact factor:   2.435


  15 in total

1.  Immunomodulatory activity of orphan drug Elmiron® in female B6C3F1/N mice.

Authors:  Sheetal A Thakur; Abraham Nyska; Kimber L White; Matthew J Smith; Wimolnut Auttachoat; Dori R Germolec
Journal:  Food Chem Toxicol       Date:  2014-03-20       Impact factor: 6.023

2.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

3.  Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective study.

Authors:  Claudio Giberti; Fabrizio Gallo; Pierluigi Cortese; Maurizio Schenone
Journal:  Ther Adv Urol       Date:  2013-08

4.  Amitriptyline: interstitial cystitis (painful bladder syndrome).

Authors:  Joyce A Generali; Dennis J Cada
Journal:  Hosp Pharm       Date:  2014-10

5.  Prevention of recurrent urinary tract infections by intravesical administration of heparin: a pilot study.

Authors:  Tova Ablove; Manish Patankar; Songwon Seo
Journal:  Ther Adv Urol       Date:  2013-12

6.  Intravesical heparin: interstitial cystitis (painful bladder syndrome).

Authors:  Joyce A Generali; Dennis J Cada
Journal:  Hosp Pharm       Date:  2013-11

7.  Managing Interstitial Cystitis/Bladder Pain Syndrome in Older Adults.

Authors:  Alyssa Gracely; Anne P Cameron
Journal:  Drugs Aging       Date:  2020-10-23       Impact factor: 3.923

Review 8.  [Diagnosis and treatment of interstitial cystitis (IC/PBS) : S2k guideline of the German Society of Urology].

Authors:  T Bschleipfer; R Doggweiler; D Schultz-Lampel; J de Jong; A Gonsior; J Hensen; E Heßdörfer; B T Kaftan; A Kuhn; U Kunzendorf; A Lampel; A Landmesser; A Loch; O Moormann; B Müller; J Neuhaus; A Reich; R Roth; S Schumacher; R Stratmeyer; W Vahlensieck; A Wördehoff; B Münder-Hensen
Journal:  Urologe A       Date:  2019-11       Impact factor: 0.639

9.  Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan.

Authors:  Won Yong Lee; Justin R Savage; Jianxing Zhang; Wanjian Jia; Siam Oottamasathien; Glenn D Prestwich
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

Review 10.  Interstitial cystitis/painful bladder syndrome: the influence of modern diagnostic criteria on epidemiology and on Internet search activity by the public.

Authors:  Niall F Davis; Sanjith Gnanappiragasam; John A Thornhill
Journal:  Transl Androl Urol       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.